Ki-67在肺硬化性血管瘤中的表达及临床意义
被引量:1
摘要
肺硬化性血管瘤(PSH)由Liebow和Hubbell在1956年首先报道。最初认为是血管起源,近年来的研究认为该肿瘤为起源于原始呼吸道上皮细胞的一种良性肿瘤,但随着研究的深入和病例的增多,
出处
《中国药物与临床》
CAS
2010年第7期815-816,共2页
Chinese Remedies & Clinics
参考文献10
-
1Kim GY,Kim J,Choi YS,et al.Sixteen cases of sclerosing hemangioma of the lung including unusual presentations.J Korean Med Sci,2004,19(3):352-358.
-
2Nakatani Y,Inayama Y,Kamijo S,et al.Selerosing lung hemangioma.Am J Surg Pathol.1999,23(2):240-243.
-
3Miyagawa-Hayashino A,Taselaar HD,Langel DJ,et al.Pulmonary sclerosing hemangioma with lymph node metastases:report of 4 cases.Arch Pathol Lab Med,2003,127(3):321-325.
-
4Gerdes J,Schwab U,Lemke H,et al.Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.Int J Cancer,1983,31(1):13-20.
-
5Devouassoux-Shisheboran M,Hayashi T,L innoila RI,et al.A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies TTF-1 is expressed in both round and surface calls,suggesting an origin form primitive respiratory epithelium.Am J Surg Pathol,2000,24:906-916.
-
6王妍,王恩华,吴广平,张志坤,林东.肺硬化性血管瘤免疫标记及超微结构——提示其细胞的不同来源[J].中国肺癌杂志,2003,6(2):92-96. 被引量:34
-
7齐凤杰,张秀伟,张永兴,戴顺东,王恩华.所谓肺硬化性血管瘤组织中两种主要细胞的雄激素受体、磷酸甘油酸酯激酶基因多态性分析[J].中华病理学杂志,2006,35(5):267-271. 被引量:18
-
8Chan AC,Chan JK.Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1(TIT-1):a new clue to its histogenesis.Am J Surg Pathol,2000,24(11):1531-1536.
-
9Yano M,Yamakawa Y,Kiriyama M,et al.Diagnosis of visceral pleural invasion by lung cancer using intraoperative touch cytology.Ann Thorac Surg,2002,73(5):981-983.
-
10Pugsley JM,Schmidt RA,Vesselle H,et al.The Ki-67 index and survival in non-small cell lung cancer:a review and relevance to positron emission tomography.Cancer,2002,8:222.
二级参考文献25
-
1Liebow AA, Hubbell DS. Sclerosing hemangioma ( histiocytoma,Xanthoma) of the lung. Cancer, 1956,9:53-75.
-
2Hill GS, Eggleston JC. Electron microscopic study of so-called "pulmonary sclerosing he mangioma". Report of a case suggesting epithelial origin. Cancer, 1972,30 : 1092-1106.
-
3Wang E, Lin D, Wang Y, et al. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol,2004,35:503-508.
-
4Lyon MF. X-chromosome inactivation and developmental patterns in mammals. Biod Rev Camb Philos Soc, 1972,47 : 1-35.
-
5Lucas DR, Shroyer KR, McCarthy PJ, et al. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol,1997,21:306-311.
-
6Perren A, Roth J, Muletta-Feurer S, et al. Clonal analysis of sporadic pancreatic endocrine turnouts. J Pathol, 1998,186:363-371.
-
7Gilliland DG, Blanchard KL, Levy J, et al. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A,1991,88:6848-6852.
-
8Lee SD,Shroyer KR,Markham NE,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest, 1998,101:927-934.
-
9Vogelstein B, Fearon ER, Hamilton SR, et al. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science, 1985, 227:642-645.
-
10Allen RC ,Zoghbi HY, Moseley AB, et al. Methylation of HpaⅡ and HhaⅠ sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet, 1992,51 : 1229 -1239.
共引文献49
-
1张丽娟,杨承纲,李梅,陈芸.肺硬化性血管瘤3例报道及文献复习[J].现代肿瘤医学,2006,14(1):38-39. 被引量:3
-
2王冬滨,赵锡江.肺硬化性血管瘤的诊断与治疗——附15例临床分析[J].中华肿瘤防治杂志,2006,13(4):308-309. 被引量:4
-
3齐凤杰,张秀伟,王恩华.所谓肺硬化性血管瘤组织中p53和PCNA蛋白表达及意义[J].中国误诊学杂志,2006,6(20):3898-3900. 被引量:4
-
4王宏伟,王书轩,丁长伟.肺硬化性血管瘤的CT表现[J].中国医学影像学杂志,2007,15(1):44-45. 被引量:17
-
5史讯,张志勇,张兴伟,候君.肺硬化性血管瘤的CT表现与病理对照分析(附21例报告)[J].实用放射学杂志,2007,23(3):311-314. 被引量:65
-
6袁素,龚选举,万珍玲.肺硬化性血管瘤临床病理分析(附5例报道并文献复习)[J].中国热带医学,2007,7(8):1378-1379. 被引量:1
-
7王宝生.肺硬化性血管瘤[J].武警医学院学报,2007,16(5):573-575. 被引量:2
-
8张丽娟,向旭东.肺硬化性血管瘤的临床病理特点[J].临床肺科杂志,2008,13(1):7-8. 被引量:12
-
9张晓林.肺硬化性血管瘤的CT表现[J].实用医技杂志,2007,14(31):4274-4276. 被引量:1
-
10齐凤杰,张秀伟,王恩华.所谓肺硬化性血管瘤组织中Cox-2、bcl-2蛋白表达及意义[J].中国误诊学杂志,2008,8(4):761-763.
同被引文献9
-
1齐凤杰,赵树鹏.p16蛋白及Ki-67在所谓肺硬化性血管瘤细胞中的表达及意义[J].山东医药,2011,51(20):67-69. 被引量:1
-
2薛仰群,王丽霞,白玮,畅俊平,李丽,李素红.Ki-67与p53在肺硬化性血管瘤中的表达及其临床意义[J].肿瘤研究与临床,2011,23(9):610-612. 被引量:3
-
3唐甜,张端莲.应用量子点技术检测Bcl-2和P53在皮肤血管瘤中的表达[J].华中科技大学学报(医学版),2013,42(2):176-180. 被引量:5
-
4周梅,江仁兵,白靖平,张焕,叶明.GLUT1、VEGF、Ki67蛋白在血管瘤和血管畸形中的表达及其意义[J].新疆医科大学学报,2014,37(12):1577-1580. 被引量:3
-
5杨秋蓝,唐兵,周晓辉,王剑鹏,王红月,王水云.心脏海绵状血管瘤的临床表现及外科手术疗效分析[J].中华心血管病杂志,2017,45(9):786-790. 被引量:8
-
6无,林晓曦.血管瘤和脉管畸形的诊断及治疗指南(2019版)[J].组织工程与重建外科杂志,2019,15(5):277-317. 被引量:256
-
7薛娟,高磊,王艳秋.VEGF、Ang-2在血管瘤中的表达及临床意义[J].实验与检验医学,2019,37(6):1067-1071. 被引量:4
-
8黄崇青,黄景勇,裘益辉.VEGF-A和VEGF-C双拮抗抑制血管瘤内皮细胞增殖的实验研究[J].浙江医学,2021,43(4):364-367. 被引量:4
-
9王逸姝,华晨,林晓曦.先天性血管瘤的遗传学研究进展及潜在药物治疗靶点[J].中华整形外科杂志,2021,37(9):1057-1062. 被引量:3
-
1张昶,刘海燕,乔海国,吴健.肺硬化性血管瘤的组织发生及p63表达的意义[J].临床与实验病理学杂志,2012,28(11):1243-1245. 被引量:4
-
2刘东.肺硬化性血管瘤的临床病理特点及鉴别诊断[J].实用肿瘤学杂志,2003,17(1):45-47.
-
3王晨亮,王小莉,孙世荃.大鼠呼吸道上皮细胞~3H-TdR标记指数[J].辐射防护,1991,11(3):227-229.
-
4文剑明,张萌.人胚呼吸道上皮细胞非时序DNA合成[J].中山医科大学学报,1992,13(1):27-30.
-
5祁敏现,吉庆明,盛喜玲.肺硬化性血管瘤的临床病理学研究[J].医药论坛杂志,2007,28(21):3-5. 被引量:1
-
6普文静,周子淮,孙振柱.肺硬化性血管瘤临床病理特点及免疫表型分析[J].新疆医科大学学报,2011,34(8):872-875. 被引量:1
-
7李楠,葛霞,冯振中,李涤臣.肺硬化性血管瘤2例报道及文献复习[J].蚌埠医学院学报,2009,34(5):398-400.
-
8黄礼燕,张声.MUC13的研究进展[J].临床与病理杂志,2014,34(3):312-316. 被引量:5
-
9王丽霞,薛仰群,杨宣琴,白玮,畅俊平.应用免疫双荧光标记探讨肺硬化性血管瘤中两种细胞的意义[J].中国药物与临床,2012,12(6):734-735.
-
10周睿.肺硬化性血管瘤的临床病理特征及文献复习[J].长江大学学报(自科版)(下旬),2013,9(3):9-12.